Jinyu Bio-Technology Co Current Assets
The Current Assets of Jinyu Bio-Technology Co (600201.SS) as of Sep 12, 2026 is 2.19 B CNY. In the previous year, Current Assets was 3.02 B CNY — a change of -27.34% (lower).
Get this data via API
Financial Data API
Current Assets
2.19 BCNY
YoY
-27.34%
Last updated:
The Jinyu Bio-Technology Co Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 2.19 BCNY | -27.34% | |
| 3.02 BCNY | +12.51% | |
| 2.68 BCNY | -2.90% | |
| 2.76 BCNY | -13.38% | |
| 3.19 BCNY | +18.32% | |
| 2.69 BCNY | -27.45% | |
| 3.71 BCNY | -9.86% | |
| 4.12 BCNY | +27.90% | |
| 3.22 BCNY | +108.78% | |
| 1.54 BCNY | +12.71% | |
| 1.37 BCNY | +17.82% | |
| 1.16 BCNY | -17.42% | |
| 1.41 BCNY | +6.43% | |
| 1.32 BCNY | +12.67% | |
| 1.17 BCNY | +17.46% | |
| 998.60 MCNY | +15.06% | |
| 867.90 MCNY | -2.29% | |
| 888.20 MCNY | +58.78% | |
| 559.40 MCNY | -10.44% | |
| 624.60 MCNY | -2.02% | |
| 637.50 MCNY | -1.04% | |
| 644.20 MCNY | +20.64% | |
| 534.00 MCNY | +7.38% | |
| 497.30 MCNY | +34.22% | |
| 370.50 MCNY | +22.56% | |
| 302.30 MCNY | -19.77% | |
| 376.80 MCNY | — |
Jinyu Bio-Technology Co Stock analysis
Frequently Asked Questions about Jinyu Bio-Technology Co stock
Current Assets of Jinyu Bio-Technology Co is 2.19 B CNY in 2026.
Current Assets of Jinyu Bio-Technology Co changed from 3.02 B CNY to 2.19 B CNY, representing a -27.34% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Jinyu Bio-Technology Co historically and in real time.
Balance Sheet — Jinyu Bio-Technology Co
All Key Metrics — Jinyu Bio-Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth